Last reviewed · How we verify

NCT04660942

Child Development and Genetic Biomarkers

Status unknown Last updated 17 December 2020
What this trial tests

trial in Child Development in 446 participants. Status unknown.

Timeline
1 December 2020
Primary endpoint
30 November 2023
28 February 2024

Quick facts

Lead sponsorChang Gung Memorial Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment446
Start date1 December 2020
Primary completion30 November 2023
Estimated completion28 February 2024
Sites1 location across Taiwan

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 1 to 18, any sex, with Child Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study of the relation between genetic biomarkers and child development in Taiwan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Child Development

Currently open trials in the same condition.

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04660942.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing